Whole EU Medtech Industry Behind Latest Push To Have MDR Problems Tackled At Highest Levels
Executive Summary
The number of attempts to persuade EU decision-makers to take radical action to alleviate the MDR implementation pressures is growing exponentially as voices turn into a loud clamor for change.
You may also be interested in...
Define, Identify And Protect: How EU Regulators Can Prevent Device Shortages
There are growing fears that the new EU medtech regulations could result in products used for children or rare diseases vanishing from the market. In an interview with Medtech Insight, regulatory expert Tom Melvin explains how these devices can be protected.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.
First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve
Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.